310 BROMOCRYPTINE (CB-154) THERAPY IN CHILDHOOD ACROMEGALY
نویسندگان
چکیده
منابع مشابه
Prolactin and luteinizing hormone secretion after bromocryptine (CB-154) treatment in lactating sows and ovariectomized gilts.
The effects of bromocryptine (CB-154) on prolactin (PRL) and luteinizing hormone (LH) secretion were studied in lactating sows and ovariectomized (OVX) gilts. In Exp]. 1, the litters of four sows were standardized to four pigs each at 20 to 30 d of lactation and a cannula was placed nonsurgically into the jugular vein of each sow. Twenty-four hours later (0800 h) blood samples were taken and tw...
متن کاملFactors Determining in the Treatment of the Effectiveness of CB-154 Acromegaly
HANEW, K., SASAKI, A., SATO, S., SHIMIZU, Y., MURAKAMI, O. and YOSHINAGA, K. Foctors Determining the Effectiveness o f CB-154 in the Treatment o f Acromegaly. Tohoku J. exp. Med., 1983, 139 (1), 91-95 To predict the effectiveness of CB-154 treatment in patients with acromegaly plasma Gil changes induced by CB-154 treatment were compared with Gil responses to TRH or arginine tests performed befo...
متن کاملAcromegaly: a new therapy.
BACKGROUND The treatment of acromegaly can be challenging. Despite a multimodality approach (surgery,radiation, dopamine agonists, somatostatin analogs), many patients do not achieve normalization of serum insulin-like growth factor I (IGF-I) concentrations. METHODS The author discusses the characteristics and indications of pegvisomant therapy for patients with acromegaly and compares the us...
متن کاملMedical Therapy of Acromegaly
This paper outlines the present status of medical therapy of acromegaly. Indications for permanent postoperative treatment, postirradiation treamtent to bridge the interval until remission as well as primary medical therapy are elaborated. Therapeutic efficacy of the different available drugs-somatostatin receptor ligands (SRLs), dopamine agonists, and the GH antagonist Pegvisomant-is discussed...
متن کاملAcromegaly and Gigantism: Including a New Syndrome in Childhood.
The characteristic endocrine giant is a patient with an eosinophil adenoma of the anterior pituitary gland, the hypersecretion of growth hormone having been operative before union of the ephiphyses of the long bones and subsequently producing the added complication of acromegaly if the hypersecretion continues in late adolescence or adult life. In relatively minor degree both gigantism and acro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Research
سال: 1978
ISSN: 0031-3998,1530-0447
DOI: 10.1203/00006450-197804001-00315